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This study aimed to determine whether the anti-inflammatory drugs that are most commonly consumed 
in Brazil, including diclofenac, ketoprofen, naproxen, indomethacin, ibuprofen and acetaminophen, 
are present in drinking water and to derive guideline values to characterize the human risk. These 
pharmaceuticals were quantified in surface waters by LC-MS/MS with solid phase extraction, both 
before and after conventional treatment on a laboratory scale, using a jar test assay. The methods used to 
quantify these drugs showed good results: the chromatographic analysis obtained correlation coefficients 
between 0.9952 and 0.9991, with limits of quantification of 0.5 ng.mL-1 - 50 ng.mL-1 and precision standard 
deviations (0.08 - 2.08). Only ketoprofen and ibuprofen were not completely removed through the jar 
test. Environmental samples were collected and handled by the same method; the values  obtained for 
ketoprofen and ibuprofen after treatment were 18.67 – 19.65 ng.L-1 (±17%) and 166.70 – 244.73 ng.L-1 
(±14%), respectively. Human risk was assessed by comparing the guideline values for each compound 
to the concentrations obtained in the environmental samples, considering the toxicological backgrounds, 
following WHO (2011) method. The results suggest that the concentrations of ketoprofen and ibuprofen 
found in drinking water do not pose a risk to human health, even with chronic consumption. 
Keywords: Emerging contaminant. LC-MS/MS. Human risk assessment. Pharmaceuticals in drinking 
water.
INTRODUCTION
Until the 1970s, the worldwide concern with water 
quality was mainly limited to its microbiological aspects. 
The interest of the scientific community and researchers 
in evaluating the presence of xenobiotics or emerging 
contaminants in different environments, such as the 
aquatic environment, led to the creation of environmental 
protection agencies such as the USEPA (United States 
Environmental Protection Agency) in 1970. Since then, 
many studies have been published about the presence 
and possible toxicity of drugs and their transformation 
products in the environment (Ternes, 2001; Raimundo, 
2007; Kumar, Chang, Xagoraraki, 2010; Richardson, 
Ternes, 2011; Richardson, 2012; Stuart et al., 2012; Leung 
et al., 2013; Cai et al., 2015). 
In 2008, Brazil was ranked first among Latin 
American countries and 50th in the world in terms of 
the excessive use of medications (Souza, Silva, Neto, 
2008). Such consumption and production may lead to 
the shedding of pharmaceuticals in wastewater, either 
as a result of human metabolism or by industrial spill. 
Pharmaceuticals and personal care products are the groups 
that are most frequently found in surface and drinking 
waters (Stumpf et al., 1999; Richardon, 2012; Cai et al 
2015). The detection of these pharmaceuticals in drinking 
water raises considerable public concern, especially when 
human-based guideline values are not available (Schriks 
et al., 2010).
Such contaminations are not recent events; the first 
findings on the occurrence of drug residues in an aquatic 
environment date to 1965 and were related to drugs and 
M. C. N. Pais, E. S. Nascimento
Braz. J. Pharm. Sci. 2018;54(1):e17320Page 2 / 10
substances that could interfere with the endocrine system. 
In 1976, Garrison, Pope and Allen used extractive methods 
and chromatographic analysis to report on the presence of 
other contaminants in waste water treatment plants in the 
United States.
New technologies allowed for the development of 
more sensitive, accurate and precise methods that can 
identify and quantify substances at concentrations as low 
as ng/L.
Even at low concentrations, the residue of 
biologically active drugs can have serious effects on 
aquatic biota, which, when they are not removed in 
sewage treatment, may result in health problems for most 
susceptible species because they can reach drinking water 
used by humans or animals (Melo et al., 2009; Cai et al., 
2015; Villanueva et al., 2014) Anti-inflammatory drugs 
are one of drugs most frequently found in the environment. 
Such contamination can cause several toxic effects 
ranging from gastrointestinal problems to kidney damage, 
particularly within sensitive populations.
Issues that are pertinent to this type of contamination 
should be investigated. Guideline values for contaminants 
must be established, and long-term studies must be 
performed to analyze their possible chronic effects 
(Ghiselli, 2006; Richardson, Ternes, 2011).
Therefore, this paper aims to contribute to the 
evaluation of the conventional process of water treatment 
in Brazil by determining the degree of retention of anti-
inflammatory painkiller drugs and deriving guideline 
values to characterize the human risk.
MATERIAL AND METHODS
Material
The drugs acetaminophen, ketoprofen, diclofenac, 
ibuprofen, indomethacin and naproxen, were purchased 
from Sigma Aldrich Brazil (batch numbers: 099K0127V; 
BCBD6676V; BCBD6672V; 122K0676V; BCBC9386V; 
078K1629) with purities ranging from 98.5 to 100%. 
Reagents, glassware and consumables: Glass fiber 
filters (GF/F 07 µm); C18 chromatographic column 
(Phenomenex – Endcapping 125 X 3 mm); automatic 
pipettes (10-40 µL; 40-200 µL); flasks (10, 25, 100 and 
1000 ml); Beakers; Isolute C18 cartridge (Sep-pak® 
Vac 6cc – 500 mg- Waters® batch: 027536242A); 
Methanol (HPLC - Carlo Erba); ammonium acetate (mass 
spectrometric grade - Carlo Erba); Acetonitrile (HPLC 
- Carlo Erba); Acetone (p.a. - Merck), acetic acid (p.a. - 
Merck), formic acid (Merck - HPLC), sulfuric acid (p.a. 
- Carlo Erba); hydrochloric acid (p.a. - Carlo Erba); C18 
cartridge (Sep-pak ® Vac 3cc - 500 mg, Waters ®batch: 
027 536 242 nd); Sodium sulfate (p.a - Merck), sodium 
formate (High-Performance Liquid Chromatography 
(HPLC) or mass spectrometric (MS)); septum vial cap 
and septum compatible with HPLC Agilent®; filter unit 
(0.22) PTFE Liquid Chromatography – Tendem mass 
spectrometry (LC/MS-MS); disposable Falcon tube 
(5 mL), test tube (10, 100 and 1000 mL), Pasteur pipettes; 
purification system Milli Q - Plus ® Millipore, Millipore 
filter ®, regular detergent, commercial humic acid (Sigma-
Aldrich).
E q u i p m e n t s :  h i g h - p e r f o r m a n c e  l i q u i d 
chromatograph coupled with a mass spectrometer 
(Applied Biosystems® - API2000/MS/MS System); 
analytical balance (Denver Instrument® APX60); 
DR/2010 Spectrophotometer - Hach Company (Serial 
No.: 000 500 018 060) and 2100N turbidimeter - Hach 
company.
Methods 
Pharmaceuticals in the environmental samples were 
quantified by LC/MS-MS after solid phase extraction 
(SPE). After quantification, the samples were subjected 
to jar testing, which mimics the steps of water treatment, 
to evaluate the amount of contaminants removed from the 
treated water.
Chromatographic method validation
To validate the chromatographic method, solutions 
with increasing concentrations of drugs (0.5 - 500 ng 
mL-1) were prepared to construct the calibration curve 
and determine the linearity, precision and accuracy of the 
method. The mobile phase consisted of Phase A (methanol) 
and Phase B (ammonium acetate 1 mM) in a concentration 
gradient ranging from 45-80% of A and 20-55% of B, an 
injection volume of 20 μL, a column temperature of 122 
°F, and a pressure of 150 bar. Electrospray ionization 
(ESI) in positive mode was used for all drugs except for 
ibuprofen, which showed better results in negative mode.
Solid Phase Extraction (SPE)
The SPE concentration of the drugs was based on 
EPA method 1694, using a C18 cartridge. This method 
enhanced the samples concentrations by approximately 
300 times (EPA, 2007).
Jar Test method
Standardization of the jar test was performed using 
samples that had been prepared in the laboratory. Known 
concentrations of the analytes of interest (ranging from 
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35 to 150 ng/L) were added to six jars (five jars with 
known concentrations and one control, in triplicate) with 
a capacity of 2 liters each, and their removal was assessed. 
Each jar was subjected to all steps of conventional 
water treatment: oxidation, coagulation, flocculation 
and disinfection with the possibility of pH, temperature, 
coagulant and chlorine adjustments throughout the 
process. All the jar tests were carried out with humic acid 
aqueous solution (20 mg L-1), which is the main component 
of organic matter that is present in natural fresh water 
(Ishiwatari, 1969). The following operating parameters 
were optimized: oxidant concentration (1-10 ppm Cl), 
pre-oxidation time (5-30 min), coagulant concentration 
(10-100 mg L-1 of FeSO4) and optimum coagulation pH 
(3-8). The maximum allowable concentration of residual 
chlorine in drinking water (2 mg. L-1) was also considered.
Analysis of the samples 
The samples were collected at Guarapiranga dam 
and at the University of São Paulo Olympic streak (São 
Paulo, Brazil) in December 2012. The first one is located 
at Alto Tietê in the southwest of São Paulo metropolitan 
region and is used as source for drinking water after 
treatment. The second one is located in the University of 
São Paulo, in the west region of the São Paulo city and is 
only used for recreation. 
Water samples were collected in white and opaque 
plastic bottles (4-10 L) that had previously been cleaned 
with regular detergent and running water; the bottles had 
screw caps and were stored in a place with temperature 
control (approximately 20 oC), for 24 hours until solid 
phase extraction and jar tests were performed. The 
parameters of color, turbidity and pH were evaluated 
before extraction and chromatographic analysis. After the 
extraction process by SPE using 1 liter of each sample, the 
samples were re-suspended in 1 ml of methanol; 300 µL 
of this solution was aliquoted and increased to a volume 
of 1 mL with water and formic acid (pH 4). Drug removal 
from water was evaluated in two spiked samples, before 
and after treatment by chromatographic analysis.
Quantitative pharmaceuticals risk assessment
Once the analytical phase was concluded, the 
quantitative pharmaceuticals risk assessment (QPhRA) 
was calculated as follows: (1) Hazard identification, (2) 
Exposure assessment, (3) Dose-response relationship, and 
(4) Risk characterization (Kumar, Chang, Xagoraraki, 
2010).
Hazard identification was supported by literature 
review; exposure assessment was based on an analysis 
of the surface water after the conventional treatment. 
The dose-response relationship was based on the 
most restrictive and relevant NOAEL (No-observed 
adverse effect level) found in the literature. The risk 
characterization was given by Hazard Quotient calculation 
(formula 2) that is the division product of Exposure Dose 
by Guideline value, according to the US EPA, 2011.
FORMULA 1 - The guideline value was found using 
formula 1, (WHO, 2011):
where: GV = Guideline Value (mg L-1 per day); bw = 
body weight (70 kg); P = fraction of the TDI allocated 
to drinking water (10-20%, usually); C = daily drinking-
water consumption (2 L day-1); TDI = Tolerable daily 
intake (mg kg-1 per day)
The guideline value is based on the multiplication 
of the Tolerable Daily Intake (mg per kg d-1) (TDI) by the 
Body Weight (BW) and the fraction of the TDI allocated 
to drinking water (P), divided by the chronic consumption 
(C). The TDI was calculated based on the most restrictive 
NOAEL, as found in literature, allocated to the factors of 
uncertainties that are applicable to each study. 
FORMULA 2 - Hazard Quotient (HQ), EPA, 2011.
where: HQ = Hazard Quotient; ED = Exposure Dose 
(mg L-1); GV = Guideline Value (mg L-1)
According to US EPA, 2011: If HQ > 1.0, then 
harmful effects cannot be ruled out; if HQ = 1.0, 
contaminant alone is not likely to cause risk; and if HQ < 
1.0, harmful effects are not likely.
RESULTS AND DISCUSSION 
Chromatographic method
The chromatographic method showed adequate 
linearity, precision, accuracy and limits of detection and 
quantification that are adequate to quantify the analytes in 
question. In all of the analyses, a weighting factor of 1/x 
for homoscedastic results, with smaller variance, was used. 
The limit of detection and quantification of the compounds 
ranged from 0.50 µg L-1 to 50 µg L-1, based on injections of 
decreasing amounts to evaluate the height of the peak and 
baseline, as presented in Table I. For all drugs a negative 
control (blank) was evaluated to guarantee the reliability 
of the method.
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The chromatogram obtained for all drugs, using the 
selected method, is shown in Figure 1.
Jar test standardization and removal evaluation
The evaluation of turbidity, color, and absorption at λ 
254 nm showed that significant reductions and/or reductions 
below the values  set out in Brazilian legislation were 
obtained only after all processing steps were done, using 
the following conditions: pre-oxidation with 1 ppm Cl (as 
NaCIO) for 10 min, 23 mg.L-1 of coagulant, and coagulation 
pH optimum between 5-6. In these conditions, the jar test 
process produced a water sample with a pH 6.0, with a color 
beneath 1 uT and a chlorine residual of 0.65 mg L-1, thus 
demonstrating that the concentrations of the added analytes 
were sufficient to ensure the reliability of the process, 
according to Brazilian decree 2914/2011. (Brasil, 2011).
The process of compound removal was shown 
to be highly capable of removing most of the analyzed 
compounds. Acetaminophen had high removal rates 
but still remained in some samples of treated water. The 
ketoprofen showed very low or no removal in alignment 
with what was found in the literature; ibuprofen showed 
great removal variation, as shown in Table I (Stumpf et 
al., 1999; Vieno et al., 2007).
Solid phase extraction
All analytes, except ibuprofen, showed the same 
recovery profile in the two homogeneous matrices: 
distilled water and water with humic acid. Acetaminophen 
had a recovery of approximately 20±2,5%, but diclofenac 
showed a high recovery of 100±7,8%. Ketoprofen also 
showed high recovery (approximately 99%), as did 
naproxen (103.4%) and indomethacin (90.3%), with 
deviations below 10%. Ibuprofen showed a wide variation 
in the first evaluated controls in both the distilled water 
matrix and the distilled water with humic acid. This 
analysis was repeated three times more with strict control 
of pH and luminosity, which resulted in an average 
recovery of 48±9.3% (58%, 47.5%, 39.5%). 
The solid phase extraction efficiency is considering 
at the end of the experiments (removal evaluation) in order 
to obtain the final real concentration. 
FIGURE 1 - Validation of the method: Chromatogram of drugs: acetaminophen, diclofenac, naproxen, ketoprofen, indomethacin 
and ibuprofen.
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Removal evaluation of the compounds in the 
environmental samples
Water from the Olympic streak showed pH 9.0, 4.38 
uT of turbidity and apparent color 52 PtCo L-1. Water from 
Guarapiranga showed pH approximately 6.0, 10.7 uT of 
turbidity and apparent color of 70PtCo L-1. Both pH values 
are in accordance with the regular pH value for superficial 
water, according to Brazilian legislation CONAMA n⁰ 
357 (Brasil, 2005).
Part of the samples (1 liter) was subjected to SPE to 
assess the actual concentration of each drug in the water in 
a triplicate analysis. This extraction method was validated 
in a similar manner as that previously performed, and 
samples were taken for chromatographic analysis. Table 
II shows the results of the SPE for the actual samples.
The water collected from the USP Olympic streak 
shows only 8 ng / L diclofenac, but in the water collected 
from Guarapiranga, all evaluated compounds were found, 
except acetaminophen, which was not detected in any of 
TABLE I - Percentage of removal of the evaluated compounds analyzed (in triplicates with SD <5% between them). Comparison 
of the peak areas before and after conventional treatment
Pharmaceuticals Jar Sample Concentration before treatment (ng ml-1)
Concentration after 
treatment (ng mL-1) Removal %
Acetaminophen
Sample 1 1650 14.1 99.14
Sample 2 2920 242.3 91.72
Sample 3 1500 <LOD 100.00
Sample 4 2210 8.7 99.60
Sample 5 1510 <LOD 100.00
Diclofenac
Sample 1 2140 <LOD 100.00
Sample 2 2990 <LOD 100.00
Sample 3 2460 <LOD 100.00
Sample 4 3290 <LOD 100.00
Sample 5 3290 <LOD 100.00
Ketoprofen
Sample 1 2110 2150 0
Sample 2 4320 4730 0
Sample 3 3360 2890 13.88
Sample 4 1460 1510 0
Sample 5 1900 1890 3.63
Naproxen
Sample 1 3220 <LOD 100.00
Sample 2 1980 <LOD 100.00
Sample 3 1700 <LOD 100.00
Sample 4 2850 3.74 99.88
Sample 5 1470 <LOD 100.00
Indomethacin
Sample 1 1910 2.82 99.87
Sample 2 2240 3.32 99.87
Sample 3 1320 2.37 99.85
Sample 4 815 3.92 99.59
Sample 5 3220 5.78 99.84
Ibuprofen
Sample 1 5940 3560 40.14
Sample 2 2830 1660 41.20
Sample 3 2370 884 62.76
Sample 4 1700 1500 11.74
Sample 5 7070 1610 77.20
< LOD: Value below the limit of detection of the analytical method
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the samples (Table III). According to Xagoraraki et al. 
(2008), acetaminophen may be degraded and transformed 
by free chlorine. The rate of this degradation is affected by 
pH and chlorine/acetaminophen molar ratio. The highest 
degradation rates were observed at pH 9.0, and the lowest 
degradation rates were observed at pH 6.0. In both cases, 
acetaminophen may be converted into the toxic byproduct, 
1,4- benzoquinone.
In addition to the SPE procedures, the jar test 
was performed using an actual sample spiked with the 
evaluated drugs. Analytes were added at concentrations 
ranging from 35-150 ng/mL. The samples were analyzed 
in triplicate, with standard deviations that ranged up to 
20%.
Table III shows that except for ibuprofen and 
ketoprofen, most of the compounds were degraded with 
the traditional method of treating water, following the 
same trend of the samples produced in the laboratory with 
humic acid and as reported by Cai et al. (2015). Diclofenac, 
indomethacin and naproxen are present in the sample from 
Guarapiranga; they are almost entirely removed in the 
water treatment station after the chlorination step.
Ketoprofen and ibuprofen, which were present in 
Guarapiranga water, were still present in the treated water 
at ng.mL-1 concentrations. A Quantitative Pharmaceutical 
Risk Assessment (QPhRA) was carried out for these two 
compounds.
Quantitative Pharmaceuticals Risk Assessment 
(QPhRA)
Human risk assessment of the compounds that were 
present in the aquatic environment and those that were not 
removed by water treatment (ibuprofen and ketoprofen) 
are discussed.
The concentrations of ibuprofen (166.70 to 
244.73 ng L-1) and ketoprofen (18.67 to 19.65 ng L-1) that 
remained in the treated water were used to assess the risk, 
though these data are not adequate to characterize the 
entire water treated by conventional methods. 
Although these drugs were present  in low 
concentrations, it is important to consider the duration of 
the exposure and the sensitive population. With chronic 
exposure, anti-inflammatory drugs can induce kidney 
damage and gastrointestinal disturbances, as well as 
dyspnea, nausea, vomiting, irritation and ulcer, as describe 
in some toxicological reviews: HSDB, 2014; ECHA, 2008 
and EMA, 1995. Based on these toxicological review 
studies of ketoprofen and ibuprofen and considering the 
most restrictive toxicological values  found in the literature 
(Tables IV and V), it was possible to determine the 
tolerable daily intake to find a threshold value (guideline 
value) to evaluate the exposure risk, according to Formula 
1, previously presented in this article.
The guideline value for ibuprofen exposure (Table 
IV), is calculated from Formula 1, where the TDI is 0.40 
mg kg-1 per day, BW is 70 kg, the P is 20% and C is 2 liters. 
per day. The result was a guideline value of 2.8 mg L-1 
per day.
The risk for ibuprofen was estimated by dividing 
244.73 x 10-6 mg L-1, the maximum concentration found 
in treated water, by the established guideline value of 2.8 
mg L-1;according to formula 2. The obtained HQ value 
was < 1.0.
The guideline value of 0.14 mg L-1 /d for ketoprofen 
exposure (table V) is calculated from Formula 1, assuming 
a TDI of 0.02 mg kg-1/d, a BW of 70 kg, P of 20% and C 
2 liters per day (WHO, 2011).
The risk for ketoprofen was estimated by dividing 
the maximum concentration found in treated water 
TABLE II - The concentrations of analytes obtained after SPE (300x concentrated) and analytes concentration in environmental 
samples (n=3), considering the SPE concentration and recovery factor
Drugs
Mean concentration after SPE * 
(ng.mL-1) Efficiency
of SPE %
Final (real) Concentration 
(ng.L-1)
USP (SD) Guarapiranga (SD) USP Guarapiranga
Acetaminophen <LOD <LOD 16-20 <LOD <LOD
Diclofenac 2.27 (11%) 8.62 (19%) 95-100 7.57-7.96 28.73 - 30.25
Ketoprofen <LOD 5.60 (17%) 90-100 <LOD 18.67 - 19.65
Naproxen <LOD 3.30 (7.5%) 95-100 <LOD 11.00 - 11.58
Indomethacin <LOD 10.70 (2.4%) 75-97 <LOD 36.77 - 47.56
Ibuprofen <LOD 29.00 (14.4%) 39.5 -58 <LOD 166.70 - 244.73
<LOD: Value below the detection limit of the method; SD: Standard Deviation. All samples were analyzed in triplicate with 
standard deviations < 20%.
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TABLE III - Mean values of concentration of analytes added before and after the jar test procedure (two samples of each compartment 
with known concentration) and removal percentage of each analyte in samples of USP Olympic Streak and Guarapiranga Dam
Olympic streak (ng.mL-1) Guarapiranga Dam (ng.mL-1)
Sample 1 Sample 2 Sample 1 Sample 2
Acetaminophen
Before 41.5 17.5
Acetaminophen
Before 34.9 53.9
After <LOD <LOD After <LOD <LOD
Removal 100% 100% Removal 100% 100%
Diclofenac
Before 93 48.8
Diclofenac
Before 81.1 157
After <LOD <LOD After <LOD <LOD
Removal 100% 100% Removal 100% 100%
Ketoprofen
Before 63.7 36.9
Ketoprofen
Before 65.23 91.07
After 54.1 43.2 After 90 118
Removal 15% 0% Removal 0% 0%
Naproxen
Before 65.4 34.7
Naproxen
Before 59.3 98.1
After <LOD <LOD After <LOD <LOD
Removal 100% 100% Removal 100% 100%
Indomethacin
Before 54.9 25.6
Indomethacin
Before 51.47 88.67
After <LOD <LOD After <LOD <LOD
Removal 100% 100% Removal 100% 100%
Ibuprofen
Before 57.66 50.17
Ibuprofen
Antes 82.7 85.5
After 37.3 50.9 Depois 93.8 90.23
Removal 35% 0% Removal 0% 0%
<LOD: below the detection limit of the method
(19.65 x 10-6 mg L-1), by the established guideline value of 
0.14 mg L-1 (Formula 2). The HQ value obtained was <1.0.
According to the guidelines and hazard quotients 
discussed above, it is clear that the concentrations of 
ibuprofen and ketoprofen found in treated water are below 
the exposure limit set for both.
CONCLUSION
The validation parameters of the chromatographic 
method used showed good linearity, accuracy and 
precision as well as an acceptable limit of detection 
and quantification for analyzing samples that contain 
diclofenac, ketoprofen, naproxen, indomethacin, 
ibuprofen and acetaminophen. The extraction method in 
solid phase showed linear values, low standard deviations 
and high precision for all samples, which made it a reliable 
extraction technique to focus on the analytes of interest. 
The removal test using the jar test values show the linear 
removal of the compounds in samples produced in the 
laboratory and in environmental samples. It is important 
to state that the experiment was done in a lab scale 
and the removal of the compounds from water may be 
overestimated once in a real scale there are a lot of other 
compounds and it is not possible to control chemical 
reaction for example.
Acetaminophen was not detected in the analyzed 
environmental samples, and spiked samples showed 
complete removal after the jar test. According to 
Xagoraraki et al. 2008, acetaminophen may be degraded 
by free chlorine, depending on the water pH and 
acetaminophen molar ratio, and it can be converted into 
the toxic byproduct 1,4-benzoquinone. Indomethacin and 
naproxen were detected only in water from Guarapiranga, 
whereas diclofenac was detected in samples from 
Guarapiranga and the Olympic streak. However, 
diclofenac showed high percentage of removal by the jar 
test after chlorination; therefore, it is unlikely to reach 
treated water.
Ketoprofen and ibuprofen peaked in water from 
Guarapiranga and had low or no percentage removal 
after treatment via jar test; thus, these two compounds 
are present in the treated water, as also reported by Cai 
et al. (2015). The removal methods of these compounds 
suggested by Melo et al. (2009) – ozonation and photo-
Fenton - are expensive and is not part of the conventional 
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ketoprofen, respectively; therefore, no significant risk to 
humans is indicated at the concentrations found. Other 
authors, such as Schwab et al. (2005) and Webb et al. 
(2003), also reported no risk or a low possibility of health 
risk due to exposure to these pharmaceuticals. In this 
study, risk assessment based on the mixture of chemicals 
was not reported.
Although indomethacin, diclofenac and naproxen 
do not show peaks in the chromatograms after water 
treatment, it does not necessarily mean that they are 
completely eliminated. Reaction with the oxidation 
products may be added to the water generated by-products, 
which are known as “disinfection byproducts” and are 
often more toxic than their precursors.
Because some of these compounds, such as 
acetaminophen and diclofenac, react with the oxidizing 
agent used in water treatment plants, disinfection products 
may be produced, which are reportedly more toxic than 
their precursors (Bedner, Maccrehan, 2006; Xangoraraki 
et al., 2008). Therefore, it is recommended to qualitatively 
and quantitatively evaluate the formation of these products 
after the chlorination process to assess human risk from 
consuming this water.
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(UF): 100
Reference dose TDI 
(based on PD/UF) 0.40 mg/kg/d
Critical effects 
(endpoint)
Statistical analysis revealed higher 
kidney weights for the animals 
receiving 100 mg/kg/day, which 
was considered to be related to 
dosing with the test substance. 
Examinat ion of  the kidneys 
revealed areas of cortical pitting 
in 9/10 receiving 100 mg/kg/day.
TABLE V - Determination of the Reference Dose of ketoprofen 
(base value for not carcinogenic substances)
Determination of the reference dose of ketoprofen
NOAEL
Based on the most restrictive 
NOAEL found in literature: dose 
of 2 mg/kg/day derived from 
the results of the teratogenicity 
toxicity study in rabbits (EMA, 
1995).
Point of departure (PD) 2 mg/kg-d
Uncertainty factors 10 animal to human;10 sensitive population
Uncertainty factor final 
(UF): 100
Reference dose (based 
on PD/UF) 0.02 mg/kg/d
Critical effects 
(endpoint) 
In  r abb i t s ,  ke top ro fen  was 
maternotoxic for doses higher 
than 2 mg/kg b.w./day after oral 
administration.
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